Skip to main content

Table 6 Ten years survival in patients with Hurthle cell carcinoma

From: Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience

 

Period of study

Number of patients

Overall survival (%)

Cancer specific survival (%)

Disease free interval (%)

Haigh et al. (SEER) [16]

1988–1993

172

73

  

Lopez-Penabad et al. [14]

1944–1995

89

55

64

 

Bhattacharyya et al. (SEER) [4]

1973–1998

555

71.1

  

Stojadinovic et al. [7]

1940–2000

56

 

73

61

Kushchayeva et al. [11]

1976–2002

33

 

49

40.5

Mills et al. [8]

1946–2003

62

 

64

43

Jillard et al. (National Cancer Database) [17]

1998–2006

1909

70.7

  

Nagar et al. (SEER-9) [1]

1975–2009

1416

77.1

  

Goffredo et al. (SEER) [2]

1988–2009

3311

 

91

 

Sugino et al. [10]

1989–2010

73

 

93.1

 

Petric et al. [6]

1972–2011

108

 

88

68

Our study

1995–2014

239

77.2

92.5

86.2

  1. SEER surveillance, epidemiology, and end results